Neu Base Therapeutics Inc (NBSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,153 | 52,893 | 31,992 | 10,314 | 250 |
| Other current assets | 0 | 0 | 0 | 266 | 0 |
| TOTAL | $24,649 | $54,929 | $32,809 | $11,029 | $250 |
| Non-Current Assets | |||||
| PPE Net | 2,157 | 2,464 | 1,167 | 431 | 0 |
| Investments And Advances | 0 | 416 | 324 | 586 | 0 |
| Intangibles | 0 | 0 | 0 | 146 | 0 |
| Other Non-Current Assets | 5,888 | 6,359 | 145 | 339 | 0 |
| TOTAL | $8,045 | $9,239 | $1,636 | $1,502 | $N/A |
| Total Assets | $32,693 | $64,168 | $34,444 | $12,531 | $250 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,843 | 1,808 | 1,505 | 1,477 | 22 |
| Accrued Expenses | 1,663 | 1,748 | 556 | 406 | 20 |
| Other current liabilities | N/A | N/A | 950 | 496 | N/A |
| TOTAL | $4,166 | $4,194 | $3,150 | $2,502 | $42 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,335 | 5,794 | 0 | 0 | 250 |
| TOTAL | $5,335 | $5,904 | $N/A | $N/A | $250 |
| Total Liabilities | $9,502 | $10,098 | $3,150 | $2,502 | $292 |
| Shareholders' Equity | |||||
| Common Shares | 3 | 3 | 2 | 2 | 1 |
| Retained earnings | -102,744 | -68,968 | -43,559 | -26,174 | -42 |
| TOTAL | $23,192 | $54,070 | $31,295 | $10,029 | $-42 |
| Total Liabilities And Equity | $32,693 | $64,168 | $34,444 | $12,531 | $250 |